Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via BSG
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Podcasts
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Podcasts
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via BSG
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 13, Issue 6
Ustekinumab for the treatment of moderate to severe ulcerative colitis: a multicentre UK cohort study
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Colorectal
Original research
Ustekinumab for the treatment of moderate to severe ulcerative colitis: a multicentre UK cohort study
Online download statistics by month:
Online download statistics by month: April 2022 to April 2023
Abstract
Full
Pdf
Apr 2022
144
7
6
May 2022
524
18
34
Jun 2022
274
22
26
Jul 2022
350
20
25
Aug 2022
117
5
12
Sep 2022
181
14
19
Oct 2022
787
66
42
Nov 2022
674
49
43
Dec 2022
349
30
20
Jan 2023
386
24
24
Feb 2023
440
20
21
Mar 2023
334
17
13
Apr 2023
339
23
23
Total
4899
315
308
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in via BSG
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF